Dr. Niraj Hiro Pahlajani, MD

Dr. Pahlajani practices at Mercyhealth Hospital and Trauma Center - Outpatient Therapy - Janesville in Janesville, Wisconsin.

Dr. Pahlajani's NPI, 1730332693, was assigned on October 23, 2008. Dr. Pahlajani graduated from Rutgers Robert Wood Johnson Medical School in 2004. Dr. Pahlajani's Texas license number on file is Q6455.

Dr. Pahlajani's primary practice is Mercyhealth Hospital and Trauma Center - Outpatient Therapy - Janesville, at 1000 Mineral Point Ave, Janesville, WI 53548. The practice phone is (608) 756-6000.

Dr. Pahlajani's primary practice is Mercyhealth Hospital and Trauma Center - Outpatient Therapy - Janesville in Janesville, Wisconsin. Dr. Pahlajani is also affiliated with Mercyhealth Hospital and Trauma Center-Janesville. The medical group on file is Mercyhealth. Dmand AI also links Dr. Pahlajani to 5 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pahlajani practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Pahlajani's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Pahlajani is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Pahlajani's licenses on file in 9 states: Texas, Arizona, Wisconsin, Wyoming, Florida, Iowa, Georgia, New Jersey and Pennsylvania.

Dmand AI lists bone cancer radiation and prostate cancer radiation among the conditions Dr. Pahlajani treats.

CMS data shows 457 Medicare services from Dr. Pahlajani across 8 procedure codes in 2024, for 104 Medicare patients. Medicare paid $29,227 for them.

CMS counts 104 Medicare patients who saw Dr. Pahlajani in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have cancer, and 74% have high blood pressure. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pahlajani's median patient age at 73, with 36% women.

In 2024, Dr. Pahlajani wrote 78 Medicare Part D claims for 54 patients. 90% of them were for generic drugs. CMS names the drug for 48 of them, across 1 drug with 11 or more claims each, at $480 in total drug cost. In 2023, CMS named 258 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Pahlajani for performance year 2024, reported through an alternative payment model (APM). Dr. Pahlajani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Pahlajani, published from 2011 to 2013. The most frequent topics are Algorithms, Radiosurgery and Radiotherapy Dosage. Dr. Pahlajani has published most often in Int J Radiat Oncol Biol Phys. Dr. Pahlajani's most frequent co-authors are Sucha O. Asbell, MD, Tamara Anne Lacouture, MD and Nazish Ahmad, DO.

CMS Open Payments shows 16 general payments to Dr. Pahlajani from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $279.

Dr. Pahlajani graduated from Rutgers Robert Wood Johnson Medical School in 2004.

Dr. Pahlajani is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.